News | July 09, 2009

Economy Forces European Institutions to Select Lower-Priced Interventional Cardiology Devices

July 9, 2009 – According to Millennium Research Group (MRG), the ongoing economic crisis is putting pressure on publicly funded European healthcare systems, intensifying the decline of interventional cardiology device prices in the region.

MRG's “European Markets for Interventional Cardiology Devices 2009 (Part II)” report details the extent to which competitive pricing and discounts among interventional cardiology device vendors is resulting in price erosion in Belgium, Luxembourg, the Netherlands, Norway, Denmark, Finland, Sweden, Spain and Switzerland.

IC device vendors are engaging in price undercutting and offering high-volume discounts or bundling deals with other products in their portfolios in order to encourage sales, resulting in price erosion. The healthcare systems in the Netherlands and Switzerland (beginning in 2012) provide only general funding for IC procedures, despite the varying cost of devices used. In order to operate within set budgets, European healthcare facilities must often choose lower-cost devices. Contract tenders between sellers and group purchasing organizations will further add to price erosion. In exchange for high-volume sales of their products, manufacturers offer significant discounts. This method of business is becoming more common across Europe, particularly in the Nordic countries and Spain.

MRG's new report provides important insight into the reasons behind and extent of the changes in interventional cardiology device pricing. Additionally, the report provides full breakdowns of procedures by type and device unit sales by subtype, including five-year forecasts, up-to-date market shares and in-depth qualitative insights.

For more information: www.MRG.net

Related Content

STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI
Feature | June 12, 2015
Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 
perfusion imaging, CT perfusion

An example of Vital Images' CT perfusion software, showing an infarct (black) and ischemic defects (dark purple). Data also can be shown on a bulls eye plot.

Feature | June 11, 2015 | Dave Fornell
Cardiac computed tomography angiography (CCTA) is known to have excellent anatomical imaging, but has lacked the...
RaySafe i2 real-time dose monitoring, radiation dose monitoring, cath lab

Real time radiation dose monitoring in the cath lab enables staff to see their level of exposure any time and can alert them when their levels are spiking. Staff wearing RaySafe i2 real-time dose monitoring badges.

Feature | May 07, 2015
Physicians and staff working in cath labs are constantly exposed to direct X-ray beams and scatter radiation....
News | April 01, 2015
UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality...
Toshiba, CT angiography, Infinix 4D CT
Technology | March 25, 2015
The U.S. Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems new Infinix 4D CT system to...
Shimadzu, Trinias C-12, First Coast Heart, angiography system, cath lab
News | February 13, 2015
Shimadzu Medical Systems announced the first United States installation of its Trinias C-12 crossover system at First...
News | January 15, 2015
The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the...
News | December 23, 2014
Philips has signed an agreement with Image Stream Medical (ISM) that allows Philips to further expand its hybrid suite...
Siemens FDA Clearance ACUSON SC2000 Prime Ultrasound System

Siemens Gains FDA Clearance of Acuson SC2000 Prime Ultrasound System.

Technology | October 21, 2014
Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the new Prime edition of...
News | September 11, 2014
U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world's...
Overlay Init